376 filings
Page 2 of 19
8-K
zgsm4mcb
7 Mar 23
Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results
7:15am
8-K
xxyffh i8nulct7v
1 Mar 23
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
4:15pm
8-K
9suamsmk7kz0
1 Feb 23
Other Events
9:00am
8-K
vd0h81o78tx090w
9 Jan 23
Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer
8:15am
8-K
vkh61dpq0mod
3 Nov 22
Xtant Medical Announces Third Quarter 2022 Financial Results
7:05am
8-K
rluik6u efdb
28 Oct 22
Departure of Directors or Certain Officers
4:15pm
8-K
y7resq5bs9n nyzo
11 Oct 22
Xtant Medical Announces Closing of Second Tranche of $9.75 Million Private Investment
8:15am
8-K
0ihevqt9ifd7ytvyo
31 Aug 22
Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment
8:15am
8-K
yeyp8km 0aabhxsa8dj
24 Aug 22
Xtant Medical Announces $9.75 Million Private Investment
8:15am
8-K
0z2gzmf4ze6yrpcz4
4 Aug 22
Xtant Medical Announces Second Quarter 2022 Financial Results
7:05am
8-K
r3upjrvf2hjs3d20ia1
5 May 22
Xtant Medical Announces First Quarter 2022 Financial Results
8:05am
8-K
cd6ibqr
2 May 22
Departure of Directors or Certain Officers
8:15am
8-K
cqd ej56g
8 Mar 22
Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results
7:10am
8-K
jp1h1m
3 Jan 22
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer
8:15am
8-K
wp6r88vihpbsm44r
12 Nov 21
Xtant Medical Announces Third Quarter 2021 Financial Results
7:10am
8-K
8utc4lsl4p7 tnqr
5 Aug 21
Xtant Medical Announces Second Quarter 2021 Financial Results
7:15am
8-K
d7r7y7kuxbqkcb562124
28 Jul 21
Submission of Matters to a Vote of Security Holders
6:45am
8-K
55zt1
20 May 21
Regulation FD Disclosure
8:44am
8-K
8yq9rc
11 May 21
Xtant Medical Announces First Quarter 2021 Financial Results
7:15am
8-K
nmhosvn
6 May 21
Entry into a Material Definitive Agreement
4:15pm